|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01420497 |
|
Date of registration:
|
18/08/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
August 2008 |
|
Target sample size:
|
25 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01420497 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diabetes stable for more than ten days
- no contraindication for steroids
- lumbar stenosis
- articular pain
Exclusion Criteria:
- unstable diabetes
- renal insufficiency
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes
|
|
Healthy
|
|
Intervention(s)
|
|
Drug: epidural infiltration
|
|
Drug: intra-articular infiltration
|
|
Primary Outcome(s)
|
|
glycemic values,
[Time Frame: day 0 to day 15]
|
|
Secondary Outcome(s)
|
|
urinary excretion rate
[Time Frame: day 0 to day 15]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|